My Watchlist Items

      No Watchlist
Array ( [0] => stdClass Object ( [symbol] => MEDS [price] => 5.35 [beta] => 1.195808 [volAvg] => 3189742 [mktCap] => 43470676 [lastDiv] => 0 [range] => 3.1-10.82 [changes] => -1.32 [companyName] => TRxADE HEALTH, Inc. [currency] => USD [cik] => 0001382574 [isin] => US89846A2078 [cusip] => 89846A207 [exchange] => Nasdaq Global Select [exchangeShortName] => NASDAQ [industry] => Pharmaceutical Retailers [website] => http://www.trxadegroup.com [description] => Trxade Group, Inc., together with its subsidiaries, owns and operates a business-to-business (B2B) web-based marketplace focused on the pharmaceutical industry in the United States. It operates through Trxade, Inc.; Community Specialty Pharmacy, LLC; Integra Pharma, LLC; and Other segments. The company operates a web based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories, and services. Its principal products and services include Trxade.com, a web-based pharmaceutical marketplace; InventoryRx.com, a web-based pharmaceutical exchange platform; Pharmabayonline that provides proprietary pharmaceutical data analytics and governmental reimbursement benchmarks analysis to the United States-based independent pharmacies and pharmaceutical databases; and RxGuru, an application, which offers product information. The company also operates a retail specialty pharmacy. In addition, it operates Delivmeds.com, a consumer-based app to provide delivery of pharmaceutical products; Trxademso.com to assist independent retail pharmacies on pricing, distribution, and logistics; and Bonum+, a B2B platform to purchase COVID-19 risk assessment and personal protective equipment tools. Trxade Group, Inc. is based in Land O'Lakes, Florida. [ceo] => Mr. Surendra K. Ajjarapu [sector] => Healthcare [country] => US [fullTimeEmployees] => 43 [phone] => 18002610281 [address] => 3840 Land O Lakes Blvd [city] => LAND O LAKES [state] => FLORIDA [zip] => 34639 [dcfDiff] => [dcf] => 6.07853 [image] => https://financialmodelingprep.com/image-stock/MEDS.png [ipoDate] => 2009-01-26 [defaultImage] => [isEtf] => [isActivelyTrading] => 1 ) )
TRxADE HEALTH, Inc. (MEDS)
   5.35   -1.32(-19.79%)
Trxade Group, Inc., together with its subsidiaries, owns and operates a business-to-business (B2B) web-based marketplace focused on the pharmaceutical industry in the United States. It operates through Trxade, Inc.; Community Specialty Pharmacy, LLC; Integra Pharma, LLC; and Other segments. The company operates a web based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories, and services. Its principal products and services include Trxade.com, a web-based pharmaceutical marketplace; InventoryRx.com, a web-based pharmaceutical exchange platform; Pharmabayonline that provides proprietary pharmaceutical data analytics and governmental reimbursement benchmarks analysis to the United States-based independent pharmacies and pharmaceutical databases; and RxGuru, an application, which offers product information. The company also operates a retail specialty pharmacy. In addition, it operates Delivmeds.com, a consumer-based app to provide delivery of pharmaceutical products; Trxademso.com to assist independent retail pharmacies on pricing, distribution, and logistics; and Bonum+, a B2B platform to purchase COVID-19 risk assessment and personal protective equipment tools. Trxade Group, Inc. is based in Land O'Lakes, Florida.
TitleNamePayCurrency PayGenderYear BornTitle Since
Executive Vice President Mr. Jariel Morales N/A USD male N/A N/A
Inhouse Counsel Mr. David M. Saslow N/A USD male N/A N/A
Chief Scientific Officer Dr. Ramesh Kenchappa M.S.(Pharma), Ph.D. N/A USD N/A N/A
Chief Financial Officer Mr. Howard A. Doss 60000 USD male 1954 N/A
Founder, Pres, Chief Operating Officer & Director Mr. Prashant Patel 150000 USD male 1974 N/A
Founder, Chairman, Chief Executive Officer, Treasurer & Sec. Mr. Surendra K. Ajjarapu 250000 USD male 1971 N/A
SymbolDateRatingRating Score Rating Details
MEDS 11 June, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 10 June, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 9 June, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 8 June, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 7 June, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 4 June, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 3 June, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 2 June, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 1 June, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 28 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 27 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 26 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 25 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 24 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 21 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 20 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 19 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 18 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 17 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 14 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 13 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 12 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 11 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 10 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 7 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 6 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 5 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 4 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 3 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 30 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 29 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 28 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 27 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 26 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 23 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 22 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 21 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 20 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 19 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 16 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 15 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 14 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 13 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 12 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 9 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 8 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 7 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 6 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 5 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 1 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
MEDS 31 March, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 30 March, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 29 March, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 26 March, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 25 March, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 24 March, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 23 March, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 22 March, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 19 March, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 18 March, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 17 March, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 16 March, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 15 March, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 12 March, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 11 March, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 10 March, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 9 March, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 8 March, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 5 March, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 4 March, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 3 March, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 2 March, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 1 March, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 26 February, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 25 February, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 24 February, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 23 February, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 22 February, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 19 February, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 18 February, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 17 February, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 5 February, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 4 February, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 3 February, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 2 February, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 1 February, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 29 January, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 28 January, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 27 January, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 26 January, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 25 January, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 22 January, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 21 January, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 20 January, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 19 January, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 15 January, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 14 January, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 13 January, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 12 January, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
MEDS 11 January, 2021 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
HolderSharesDate ReportedChange
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 5500 31 March, 2021 3000
PERRITT CAPITAL MANAGEMENT INC 135481 31 December, 2020 16386
NATIONAL ASSET MANAGEMENT, INC. 85750 31 December, 2020 85750
GEODE CAPITAL MANAGEMENT, LLC 67937 31 December, 2020 67937
RENAISSANCE TECHNOLOGIES LLC 40100 31 December, 2020 40100
ROYCE & ASSOCIATES LP 20700 31 December, 2020 -197300
CITADEL ADVISORS LLC 12700 31 December, 2020 12700
G2 INVESTMENT PARTNERS MANAGEMENT LLC 10000 31 December, 2020 -388796
BLACKROCK INC. 9186 31 December, 2020 -1240
TOWER RESEARCH CAPITAL LLC (TRC) 2146 31 December, 2020 1378
PNC FINANCIAL SERVICES GROUP, INC. 1030 31 December, 2020 1030
ADVISOR GROUP HOLDINGS, INC. 350 31 December, 2020 0
HEARTLAND ADVISORS INC 250000 31 December, 2020 -50000
WELLS FARGO & COMPANY/MN 15 31 December, 2020 0
HolderSharesDate ReportedWeight Percent
Heartland Value Fund 300000 30 June, 2020 0.35
Royce Smaller-Companies Growth Fund 197300 30 June, 2020 0.53
Perritt MicroCap Opportunitites Fund 49099 30 June, 2020 0.52
Perritt Ultra MicroCap Fund 25000 30 June, 2020 1.23
Royce Micro-Cap Trust 20700 30 June, 2020 0.03
SymbolTransaction DateReporting CikSecurities Owned Company CikReporting NameAcquistion Or DispositionForm Type Securities TransactedSecurity NameLink
MEDS 27 May, 2021 0001293970 6287 0001382574 PETERSON MICHAEL L D 4 8041 Common stock View
MEDS 27 May, 2021 0001794913 10867 0001382574 Tenaerts Pamela D 4 8041 Common stock View
MEDS 27 May, 2021 0001136354 10912 0001382574 POPE CHARLES L A 4 10912 Common stock View
MEDS 27 May, 2021 0001865857 10912 0001382574 Jennings Christine L. A 4 10912 Common stock View
MEDS 5 May, 2021 0001616905 17639 0001382574 Fell Donald G. D 4 300 Common Stock View
MEDS 4 May, 2021 0001616905 17939 0001382574 Fell Donald G. D 4 2250 Common stock View
MEDS 19 April, 2021 0001616905 20189 0001382574 Fell Donald G. A 4 10721 Common stock View
MEDS 19 April, 2021 0001293970 6287 0001382574 PETERSON MICHAEL L D 4 900 Common stock View
MEDS 19 April, 2021 0001293970 17008 0001382574 PETERSON MICHAEL L A 4 10721 Common stock View
MEDS 19 April, 2021 0001794913 18908 0001382574 Tenaerts Pamela A 4 10721 Common stock View
MEDS 19 April, 2021 0001617460 1252500 0001382574 Patel Prashant D 4 7500 Common stock View
MEDS 14 December, 2020 0001293970 7187 0001382574 PETERSON MICHAEL L D 4 1800 Common stock View
MEDS 14 December, 2020 0001616905 8487 0001382574 Fell Donald G. D 4 500 Common stock View
MEDS 14 December, 2020 0001617460 1260000 0001382574 Patel Prashant D 4 7500 Common stock View
MEDS 14 December, 2020 0001616905 9468 0001382574 Fell Donald G. D 4/A 500 Common stock View
MEDS 14 December, 2020 0001794913 8187 0001382574 Tenaerts Pamela D 4 800 Common stock View
MEDS 14 July, 2020 0001617460 1267500 0001382574 Patel Prashant D 4 7000 Common stock View
MEDS 13 July, 2020 0001617460 1274500 0001382574 Patel Prashant D 4 500 Common stock View
MEDS 12 June, 2020 0001368298 1112516 0001382574 AJJARAPU SURENDRA K D 4 201613 Common stock View
MEDS 14 April, 2020 0001616534 12500 0001382574 Doss Howard A. A 4 12500 Common stock View
MEDS 14 April, 2020 0001293970 8987 0001382574 PETERSON MICHAEL L A 4 8987 Common stock View
MEDS 14 April, 2020 0001616905 8987 0001382574 Fell Donald G. A 4 8987 Common stock View
MEDS 14 April, 2020 0001794913 8987 0001382574 Tenaerts Pamela A 4 8987 Common stock View
MEDS 14 April, 2020 0001368298 1265109 0001382574 AJJARAPU SURENDRA K A 4 74484 Common stock View
MEDS 14 April, 2020 0001368298 1314129 0001382574 AJJARAPU SURENDRA K A 4 49020 Common stock View
MEDS 14 April, 2020 0001617460 1255000 0001382574 Patel Prashant A 4 50000 Common stock View
MEDS 14 April, 2020 0001616905 9968 0001382574 Fell Donald G. A 4/A 8987 Common stock View
MEDS 1 April, 2020 0001794913 16667 0001382574 Tenaerts Pamela A 4 16667 Stock Option View
MEDS 6 January, 2020 0001616905 1381 0001382574 Fell Donald G. D 4 200 Common Stock View
MEDS 6 January, 2020 0001616905 1181 0001382574 Fell Donald G. D 4 200 Common Stock View
MEDS 6 January, 2020 0001616905 981 0001382574 Fell Donald G. D 4 200 Common Stock View
MEDS 8 October, 2019 0001616905 1581 0001382574 Fell Donald G. A 4 1000 Common Stock View
MEDS 4 October, 2019 0001616905 581 0001382574 Fell Donald G. D 4 500 Common Stock View
MEDS 9 August, 2019 0001616905 2281 0001382574 Fell Donald G. D 4 1000 Common Stock View
MEDS 9 August, 2019 0001616905 1781 0001382574 Fell Donald G. D 4 500 Common Stock View
MEDS 9 August, 2019 0001616905 1081 0001382574 Fell Donald G. D 4 700 Common Stock View
MEDS 5 August, 2019 0001616905 3281 0001382574 Fell Donald G. A 4 1000 Common Stock View
MEDS 9 July, 2019 0001616905 3281 0001382574 Fell Donald G. D 4 1000 Common Stock View
MEDS 9 July, 2019 0001616905 2281 0001382574 Fell Donald G. D 4 1000 Common Stock View
MEDS 2 July, 2019 0001616905 4281 0001382574 Fell Donald G. A 4 200 Common Stock View
MEDS 11 June, 2019 0001616905 4081 0001382574 Fell Donald G. A 4 1000 Common Stock View
MEDS 13 May, 2019 0001368298 13473750 0001382574 AJJARAPU SURENDRA K A 4 100000 Stock Option View
MEDS 13 May, 2019 0001616534 315281 0001382574 Doss Howard A. A 4 20000 Stock Option View
MEDS 13 May, 2019 0001616905 200048 0001382574 Fell Donald G. A 4 50000 Stock Option View
MEDS 13 May, 2019 0001293970 176923 0001382574 PETERSON MICHAEL L A 4 50000 Stock Option View
MEDS 13 May, 2019 0001617460 12250000 0001382574 Patel Prashant A 4 100000 Stock Option View
MEDS 11 April, 2019 0001616905 3081 0001382574 Fell Donald G. D 4 700 Common Stock View
MEDS 5 February, 2019 0001616905 3781 0001382574 Fell Donald G. A 4 2000 Common Stock View
MEDS 1 February, 2019 0001616905 1781 0001382574 Fell Donald G. D 4 700 Common Stock View
MEDS 20 December, 2018 0001616905 2481 0001382574 Fell Donald G. A 4 3 Common Stock View
MEDS 26 April, 2018 0001293970 114423 0001382574 PETERSON MICHAEL L A 4 50000 Stock Option View
MEDS 26 April, 2018 0001616905 184423 0001382574 Fell Donald G. A 4 50000 Stock Option View
MEDS 26 April, 2018 0001616534 304500 0001382574 Doss Howard A. A 4 37500 Stock Options View
MEDS 24 January, 2018 0001616905 2478 0001382574 Fell Donald G. A 4 400 Common Stock View
MEDS 20 December, 2017 0001616905 2078 0001382574 Fell Donald G. A 4 800 Common Stock View
MEDS 15 November, 2017 0001368298 13743750 0001382574 AJJARAPU SURENDRA K D 4 250000 Common Stock View
MEDS 7 April, 2017 0001293970 0 0001382574 PETERSON MICHAEL L A 5 176923 Stock Option View
MEDS 7 April, 2017 0001616905 0 0001382574 Fell Donald G. A 5 76923 Stock Option View
MEDS 30 March, 2017 0001616905 1278 0001382574 Fell Donald G. A 4 4 Common Stock View
MEDS 15 March, 2017 0001616905 1274 0001382574 Fell Donald G. A 4 500 Common Stock View
MEDS 7 March, 2017 0001616905 774 0001382574 Fell Donald G. A 4 500 Common Stock View
MEDS 30 December, 2016 0001368298 13993750 0001382574 AJJARAPU SURENDRA K D 4 156250 Common Stock View
MEDS 1 April, 2016 0001616905 25000 0001382574 Fell Donald G. A 5 25000 Stock Option View
MEDS 1 April, 2016 0001616534 15000 0001382574 Doss Howard A. A 5 15000 Stock Option View
SymbolDatePeriodDownload XLSX File
MEDS 2021 FY Download XLSX File
MEDS 2020 FY Download XLSX File
MEDS 2019 FY Download XLSX File
MEDS 2018 FY Download XLSX File
MEDS 2017 FY Download XLSX File
MEDS 2016 FY Download XLSX File
MEDS 2015 FY Download XLSX File
MEDS 2014 FY Download XLSX File
MEDS 2021 Q1 Download XLSX File
MEDS 2021 Q2 Download XLSX File
MEDS 2020 Q3 Download XLSX File
MEDS 2020 Q2 Download XLSX File
MEDS 2020 Q1 Download XLSX File
MEDS 2020 Q4 Download XLSX File
MEDS 2019 Q1 Download XLSX File
MEDS 2019 Q4 Download XLSX File
MEDS 2019 Q3 Download XLSX File
MEDS 2019 Q2 Download XLSX File
MEDS 2018 Q2 Download XLSX File
MEDS 2018 Q1 Download XLSX File
MEDS 2018 Q3 Download XLSX File
MEDS 2018 Q4 Download XLSX File
MEDS 2017 Q1 Download XLSX File
MEDS 2017 Q2 Download XLSX File
MEDS 2017 Q4 Download XLSX File
MEDS 2017 Q3 Download XLSX File
MEDS 2016 Q3 Download XLSX File
MEDS 2016 Q4 Download XLSX File
MEDS 2016 Q1 Download XLSX File
MEDS 2016 Q2 Download XLSX File
MEDS 2015 Q3 Download XLSX File
MEDS 2015 Q2 Download XLSX File
MEDS 2015 Q1 Download XLSX File
MEDS 2015 Q4 Download XLSX File
MEDS 2014 Q3 Download XLSX File
MEDS 2014 Q4 Download XLSX File
MEDS 2014 Q2 Download XLSX File

Charts

Company Historical Earnings

DateSymbolEPSEPS EstimatedTimeRevenueRevenue Estimated
26 April, 2021 MEDS -0.08 -0.08 amc 0 2240000
26 October, 2020 MEDS 0.02 0.02 amc 6332269 9498403.5
27 July, 2020 MEDS -0.07 -0.07 amc 6592640 941805.71428571
4 May, 2020 MEDS 0.02 0.02 bmo 2203320 1101660
30 March, 2020 MEDS -0.06 -0.06 bmo 1695900 0
31 October, 2019 MEDS 0 0 bmo 2311430 0
29 July, 2019 MEDS 0 0 bmo 1916410 0
14 May, 2019 MEDS 0 0 bmo 1512520 0
22 March, 2019 MEDS bmo 1293696 0
26 October, 2018 MEDS bmo 847471 0
27 July, 2018 MEDS bmo 837688 0
27 April, 2018 MEDS 0 0 bmo 852923 0
2 March, 2018 MEDS 0.02 0.02 bmo 852923 0
7 November, 2017 MEDS 0 0 bmo 690869 0
4 August, 2017 MEDS bmo 704728 0
15 May, 2017 MEDS bmo 745943 0
30 March, 2017 MEDS bmo -1857553 0
14 November, 2016 MEDS bmo 803278 0
8 August, 2016 MEDS -0.03 -0.03 bmo 1688990 0
20 April, 2016 MEDS -0.01 -0.01 bmo 1847151 1847151
29 March, 2016 MEDS -0.02 -0.02 bmo 1847151 923575.5
2 November, 2015 MEDS 0 0 bmo 1637875 0
30 July, 2015 MEDS 0 0 bmo 1167195 0
4 May, 2015 MEDS -0.06 -0.06 bmo 696133 696133
21 March, 2015 MEDS -0.12 -0.12 bmo 0 0

Company Profile

Company Name TRxADE HEALTH, Inc.
Symbol MEDS
Currency USD
Price 5.35
Exchange Name Nasdaq Global Select (NASDAQ)
Industry Pharmaceutical Retailers
CEO Mr. Surendra K. Ajjarapu
Sector Healthcare
Country US
Full Time Employees 43
Phone 18002610281
Address 3840 Land O Lakes Blvd
City LAND O LAKES
State FLORIDA
Zip 34639
>